Pangaea Oncology SA logo

PANG - Pangaea Oncology SA News Story

€2 0.0  0.0%

Last Trade - 12/05/21

Sector
Healthcare
Size
Micro Cap
Market Cap £32.2m
Enterprise Value £35.0m
Revenue £3.52m
Position in Universe 507th / 726

BRIEF-Pangaea Oncology Signs Contract With Astrazeneca For Biomarker Services Provision

Mon 17th June, 2019 1:50pm
June 17 (Reuters) - Pangaea Oncology SA  PANGO.MC :
    * SIGNS CONTRACT WITH ASTRAZENECA FOR PROVISION OF BIOMARKER
DISCOVERY SERVICES
    * SAYS CONTRACT TO LAST UNTIL MARCH 20, 2020

Source text: https://bit.ly/2KVyzXl
Further company coverage:  PANGO.MC 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.